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A comparative study of enzyme activity features of thymidilate “salvage pathway” synthesis in blood serum and tissues of different 
age patients with gastric cancer (T3–4N0-xM0) was carried out. Aim: To evaluate the diagnostic relevance of thymidilate metabolism 
enzymes activities and their association with tumor growth. Methods: Enzymes activities were determined by the radioisotope 
method and spectrophotometrically in tumor tissues and blood serum of 74 patients. Results: It was demonstrated that thymidine 
phosphorylase activity in gastric tumors is lower by 2.6 times as compared to non-neoplastic mucosa of resection margin. This 
being accompanied by decrease of its activity in the blood serum (from 47.9 ± 2.6 to 14.65 ± 2.4 nmol/min·mg, p < 0.001). An in-
crease of thymidine kinase activity was revealed both in tumor tissues (more than 3.5 times) and in blood serum (from 
3.9 ± 0,7 nmol/mg·h, to 6.8 ± 1.0 nmol/mg·h, p < 0.01). Changes in their activity in the postoperative period depended on the 
type of surgical procedure and tumor eradication. Conclusion: It could be suggested that control of individual dynamics of the en-
zymes activities in blood serum may be used as informative tool for monitoring of patients and treatment optimization.
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Metabolic disorders associated with malignant 
transformation and tumor progression result from 
quantitative imbalance of enzymatic processes. One 
of the biological features of tumor cells is an opposite 
change in enzymes activity of anabolic and catabolic 
processes. Besides the intensity of cellular DNA synthe-
sis and, thus, cell division, depends on the level of de-
oxythymidine triphosphate (dTTP, the key precursor 
for DNA synthesis). In human body DNA is synthesized 
following one of the two possible pathways. There are 
both de novo synthesis (from simple precursors) and 
“salvage pathway”, for example, by recycling thymine 
which can be reincorporated into DNA. The intensity 
of “salvage pathway” is regulated by the activity of two 
enzymes — thymidine phosphorylase (TP; E C 2.4.2.4.) 
and thymidine kinase (TK; E C 2.1.2.1.) (Fig. 1). TK and 
TP also play an important role in thymidine homeostasis 
and thus in the synthesis of dTMP (a precursor of dTTP 
in DNA synthesis). TK has a key function in the synthesis 
of DNA and, thereby, in cell division as it is part of the 
unique reaction chain to introduce deoxythymidine into 
DNA. TK reflects proliferative activity. It is used as a pro-
liferation marker in the diagnosis, a control of treatment 
and follow-up of malignant disease [1]. Thymidine 
phosphorylase (TP) is similar to the platelet-derived 
endothelial cell growth factor (PD-ECGF) and plays dual 
role in cell biology. A high expression is related to tumor 
angiogenesis and invasion, and therefore it is associ-
ated with a poor prognosis. It has been postulated that 
the angiogenic effect of PD-ECGF/TP is related to the 
enzymatic activity of TP, which catalyses the reversible 
phosphorolytic cleavage of thymidine (TdR) to thymine 
and 2´-deoxyribose-1-phosphate (dR-1-P) [2].
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Fig. 1. Schematic representation of the thymidilate synthesis 
by the “salvage pathway”
Enzyme can also catalyze the interconversion 
of uracil, as well as several fluoropyrimidines. It has also 
an important pharmacological action. TP has a moderate 
of even negligible role in the activation of the antime-
tabolite 5-fluorouracill (5-FU) to fluoro-deoxyuridine-5´-
monophosphate, but its phosphorolytic activity is essen-
tial for the activation of prodrug 5´-deoxy-5-fluorouridine 
(5´-DFUR, furtulon) to 5-fluorouracil. 5-FU is an interme-
diate in the activation of the prodrug capecitabine (Xe-
loda). The various complex interactions of TP/PD-ECGP 
give it an essential role in cellular functioning, and hence 
it is an ideal target in cancer chemotherapy.
Since last century, the 5-FU with other anticancer 
agents and prodrugs from group of fluoropyrimidines 
are widely used. For example: capecitabine (Xeloda), 
tegafur, furtulon (5´-deoxy-5-fluorouridine, 5´-DFUR), 
S-1 and other [3]. These drugs provide the basis for 
neoadjuvant and adjuvant chemotherapy in combi-
nation with various types of surgical procedures and 
different methods of polychemotherapy (PCT) (endo-
lymphatic and intra-arterial chemotherapy).
This study evaluates the possibility of thymidilate 
metabolism biomarkers using in the clinical practice. 
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In addition, we investigate the individual enzymatic 
test as an estimate of anticancer treatment efficacy 
and prognosis of disease recurrence.
MATERIALS AND METHODS
Seventy-four adult patients, 25–70 year old, with 
gastric cancer were included in this study. Patients 
were staged in the accordance with TNM classification 
(the 6th edition) as T3–4N0-xM0. Eighty-two non-cancer-
ous patients of the same age without gastroduodenal 
zone pathology formed control group and also were 
examined. The study protocol was approved by Ethical 
Committee permission of M. Gorky National Medical 
University (Donetsk, Ukraine) for studies with human 
materials. The features of enzymes activity were 
studied in blood serum and tissues. Activity of tissue 
enzymes was determined in the surgically removed 
material in thirty tumors and in non-cancerous sto-
mach mucosa (the mucosa margin of resection distant 
from the carcinoma had being as a control).
Survival retrospective analysis when different ways 
of chemotherapeutic agent’s injections was made 
in 125 cases of inoperable gastric cancer.
Preparation of tissue and serum samples was real-
ized by standard methods. Briefly, tissues were homog-
enized in 10 mM Tris-HCL buffer (pH 7.5) containing 
0.1mM KCL, 2 mM sucrose. Samples were centrifuged 
at 5.000 g for 30 min and the supernatants were used 
for the enzyme assay. TK activity was determined 
by the radioisotope method as described previously 
[4]. Radioactivity of diethyl-amino-ethyl-cellulose pa-
per disks (DEAE-cellulose disks paper “Limbro” (UK) 
was counted in a liquid scintillation SL-8 on a biologi-
cal scintillation counter (CBS-2, Russia). TK activity 
was given in nanomoles of thymidylate formed within 
an hour per 1 mg of protein. TP activity was determined 
spectrophotometrically at 300 nm according to the 
amount of thymine formed [4]. From each supernatant, 
0.02 ml of it was incubated with 50 mM potassium phos-
phate buffer and 10 mM thymidine (“Sigma”, Germany) 
in a total volume of 1 ml. After incubation for 30 min 
at 37 0C, the reaction was terminated by boiling and add-
ing 2.5 ml of 0.1 M NaOH. Activity was given nanomoles 
of thymine generated per 1 min/mg of protein. Protein 
concentration in biological material was determined 
using the method described by Lowry et al. [5].
Statistical analysis of results was performed using 
Medstat software package. On significance of differ-
ences was analyzed by parametric and nonparametric 
methods.
RESULTS AND DISCUSSION
The blood serum is the most available material for 
patients monitoring. We studied features of enzyme 
activity both in the tumor tissue and blood serum 
of patients with gastric cancer, and in the blood serum 
of the healthy persons (Table 1). There is evidence 
that TK demonstrates the highest level of activity in the 
blood of healthy persons at the age of 46–60 years. 
The relationship between parameters was assessed 
statistically using Spearman’s rank correlation test, i.e., 
rho = 0.519, a positive correlation between the TK activ-
ity and age was shown. Therefore, we determined the 
possibility of TMP synthesis increasing by the “salvage 
pathway” in healthy individuals aged 46–60 years. 
However, an age-dependent activity increase is also 
characteristic of TP (the index of Spearman’s rank cor-
relation, i.e., rho = 0.874, a positive correlation between 
the TP activity and age). It is interesting to note that 
direct correlation between anabolism and catabolism 
enzymes activity (TK, TP) can regulate the rate of their 
pathway dTTP synthesis in healthy organism.
Table 1. The “salvage thymidilate synthesis” enzymes activity in serum 
in control group and gastric cancer patients at the different age
Age (years) TK (nmol/mg·h) TP (nmol/mg·min)Control GC Control GC
25—35 2.67 ± 0.34 - 36.16 ± 2.15 -
36—45 2.96 ± 0.51 5.98 ±1.10* 41.61 ± 3.12 35.26 ± 3.12
46—60 3.87 ± 0.71 6.78 ± 0.98* 47.88 ± 2.62 14.65±2.38***
61—70 3.05 ± 0.32 4.28 ± 0.89* 52.01 ± 2.89 17.32±2.28**
Notes: GC — gastric cancer; authentic differences versus normal 
value:*р < 0.05, **р < 0.01, ***р < 0.001.
It has been determined that in case of gastric 
cancer development the age-dependent property 
of TP activity was lost. A negative correlation between 
the TP activity in the blood serum and age was exposed 
(rho = — 0.189). In this case the increasing of TK ac-
tivity was accompanied by decreasing of TP activity 
in the blood serum of patients with gastric cancer. This 
disorder may be one of the reason of dTTP synthesis 
increasing and higher rate of proliferation.
TK and TP activity changes in the blood serum 
of patients with gastric cancer demonstrate their ac-
tivity peculiarities in tissues (Fig. 2). It has been found 
that TP activity was decreased in the tumor tissue 
up to 21.9 ± 8.6 nmol/mg·min in comparison with non-
tumor mucose (57.82 ± 8.0 nmol/mg·min, p < 0.01) that 
was accompanied by decreasing of its activity in blood 
serum (up to 14.65 ± 2.4 nmol/mg·min, p < 0.001). The 
TK activity increase both in tumor tissues (more than 
3.5 times) and in blood serum was determined.
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Fig. 2. The thymidine kinase activity in the blood serum of control 
group, patients with gastric cancer at the age of 46–60 years 
(nmol/mg·h)
According to the obtained findings as well as the re-
sults of our previous studies [4, 6] the activity of serum 
enzymes correlates with their activity in the tissues. 
Our findings comply with the results of other authors 
[7]. It is known that metabolic features of tumors can 
be due to their ability to express the embryonal forms 
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of the enzymes. In particular, it was shown the exis-
tence of several cellular forms of thymidine kinase: 
two mitochondrial TK isozymes — thymidine kinase 
A, which is localized mainly in their matrix, and thymi-
dine kinase B — isozyme of the inner mitochondrial 
membrane. These proteins differ not only for physi-
cal and chemical properties, but also the sensitivity 
to chlorphynicole inhibition. A-isozyme is a predomi-
nant mitochondrial enzyme. It is determined in slowly 
proliferating tissues of adult animals and manifests 
a stable activity throughout its life. However, it is estab-
lished that the major part of the enzyme in the cultures 
actively proliferating normal and tumor cells is local-
ized in the cytoplasm. It has also been established 
that TK isozymes of the human of mitochondrial and 
cytoplasmic localization are expressed by different 
genes from chromosomes 16 and 17. Cytoplasmic 
thymidine kinase is named “embryonal” isozyme. 
It has different from mitochondrial protein physical 
and chemical properties — the isoelectric point, the 
sedimentation rate, electrophoretic mobility in poly-
acrylamide gel, specificity to phosphate donor [1]. 
It is TK “embryonic” that can phosphorylate thymi-
dine for the synthesis of nuclear DNA, and its activity 
is directly correlating with the cellular proliferation 
rate. It has been determined that TK maximum acti-
vity of different incubation regimes has differed from 
physiological one (Fig. 3). As the maximum TK acti-
vity of blood serum of healthy people of different age 
is registered at 20th minute of incubation in the reaction 
medium, and two-stage activity increase at 10th minute 
is characteristic of TK blood of oncologic patients, 
and activity maximum is registered at 30th minute. The 
obtained data can be probably associated with of the 
“embryonal” isozyme expression increase, as it has 
been established that tumor isozyme is determined 
not only in tissues, but in patients’ blood as well.
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Fig. 3. Effect of different time of incubation on the thymidine 
kinase activity in the blood serum of control group, patients with 
gastric cancer at the age of 46–60 years (nmol/mg·h)
Different localization in the cytosol and in the nucle-
us is characteristic of TP as well, which may indirectly 
indicate the presence of isozyme forms too [8, 9]. The 
possibility of enzymatic tests using for diagnosis of re-
currence, for individualization of chemotherapy was 
also studied. For this purpose the dynamics of TK and 
TP activity changes in the blood serum of patients with 
gastric cancer at pre- and post-operative periods was 
studied (the activity investigation was made every 
other 3 days within 14 days). Several groups were 
formed according to peculiarities of the enzymes 
activity (Table 2). They turned out to depend on the 
amount of tumor eradication, i.e., according to the 
type of surgical intervention (Table 2). Thus, it was 
registered the decrease of TK activity after radical 
surgery followed by reaching the normal value (2.1 ± 
0.6 nmol/mg·h). TP activity was increased up to 38.3 ± 
1.95 nmol/mg·min with reaching the normal level later.
At the same period following palliative operations 
the TK activity on day 6 after the surgical interven-
tion began to increase (a dangerous symptom) and 
up to the end of the second week it exceeded the initial 
preoperative activity reaching 5.50 ± 0.45 nmol/mg·h. 
Simultaneously TP activity was decreased to the initial 
values. Thus, one can suppose that individual monitor-
ing of TK and TP activity demonstrates the character 
of surgery and volume of tumor eradication.
Another aspect of the given study was to evaluate 
the effectiveness of different methods of chemo-
therapy according to the analysis of survival in groups 
of patients with unresectable gastric cancer treated 
with PCT scheme PF (5-fluorouracil and platinum). 
Out of 125 patients 45 patients took an endolymphatic 
infusions of chemotherapeutic agents, 50 — took 
the antitumoral agents by intra-arterial infusions and 
30 patients had the prolonged intravenous PCT. It has 
been determined that survival rate of the patients with 
predominantly infiltrative form of tumor growth (T4, 
infiltration of the surrounding organs, retroperitoneal 
spread) treated by endolymphatic PCT was 11.6 months 
that was higher than those of patients with the meta-
static form of tumor growth (T3–4, M1) — 6.5; survival 
rate of patients treated by intra-arterial PCT — 12.4 vs. 
4.5 months, and that of patients treated by intravenous 
PCT 8.9 and 8.8 months.
The present study suggests that the efficiency 
of PCT performed by different ways of the drugs 
administration may be associated with the character 
of tumoral process spread [10]. The recommenda-
tions for the different ways of 5-FU administration 
may be based on the previously stated peculiarities 
of pharmacokinetics [11]. It was demonstrated that the 
5-fluorouracil maximum concentration in the tumor tis-
sue by endolymphatic or intra-arterial infusion exceeds 
those after intravenous infusion and provides more 
prolonged effect on tumor cells. Besides, by endolym-
Table 2. The association between serum enzymes activity and volume of surgical intervention
Enzymes activity
The type of surgery
Radical Diagnostic Palliative
before after 2 weeks before after 2 weeks before after 2 weeks
ТК, nmol/mg·h 6.29 ± 1.47 2.09 ± 0.56* 6.43 ± 1.76 4.02 ± 0.45 4.17 ± 0.66 5.50 ± 0.45
ТP, nmol/mg·min 15.28 ± 2.02 38.33 ± 1.95** 10.03 ± 2.41 11.43 ± 2.22 13.0 ± 1.88 14.52 ± 1.67
Note: authentic differences versus normal value: * р < 0.05, ** р < 0.01.
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phatic administration there was noted a high selectivity 
of 5-FU accumulation in the tumor tissue, the parietal 
peritoneum and retroperitoneal lymph nodes [11]. 
It is important to note that intraoperative setting of per-
manent catheter according to techniques worked out 
in Donetsk Regional Anticancer Center allows to carry 
out up to 5 cycles of intra-arterial PCT (25 long-term 
intra-arterial injections of 5-fluorouracil) [12], that is not 
possible while dealing with traditional catheterization 
of gastric arteries according to Seldinger.
Obtained results allow to suggest that the control 
of individual dynamics of TK and TP activity in blood 
serum of gastric cancer patients may be useful as in-
formative tool for monitoring of patients and treatment 
optimization.
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